146 related articles for article (PubMed ID: 32404621)
1. Cessation of Long-term Topical Steroids in Adult Atopic Dermatitis: A Prospective Cohort Study.
Sheary B; Harris MF
Dermatitis; 2020; 31(5):316-320. PubMed ID: 32404621
[TBL] [Abstract][Full Text] [Related]
2. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis.
Furue M; Terao H; Rikihisa W; Urabe K; Kinukawa N; Nose Y; Koga T
Br J Dermatol; 2003 Jan; 148(1):128-33. PubMed ID: 12534606
[TBL] [Abstract][Full Text] [Related]
3. Topical steroids for atopic dermatitis in primary care.
Drug Ther Bull; 2003 Jan; 41(1):5-8. PubMed ID: 12611357
[TBL] [Abstract][Full Text] [Related]
4. A Qualitative Study Exploring the Views and Experiences of Adults Who Decided to Cease Long-term Topical Steroid Use.
Sheary B; Tyson C; Harris MF
Dermatitis; 2021 Nov-Dec 01; 32(6):e131-e133. PubMed ID: 33654020
[No Abstract] [Full Text] [Related]
5. [Constitutional eczema; the possibilities of local treatment].
Sillevis Smitt JH
Ned Tijdschr Geneeskd; 2002 Mar; 146(9):400-4. PubMed ID: 11901940
[TBL] [Abstract][Full Text] [Related]
6. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
7. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis.
Furue M; Terao H; Moroi Y; Koga T; Kubota Y; Nakayama J; Furukawa F; Tanaka Y; Katayama I; Kinukawa N; Nose Y; Urabe K
J Dermatol; 2004 Apr; 31(4):277-83. PubMed ID: 15187322
[TBL] [Abstract][Full Text] [Related]
8. Steroid phobia on social media platforms.
Nickles MA; Coale AT; Henderson WJA; Brown KE; Morrell DS; Nieman EL
Pediatr Dermatol; 2023; 40(3):479-482. PubMed ID: 36815409
[TBL] [Abstract][Full Text] [Related]
9. Interventions to reduce Staphylococcus aureus in the management of eczema.
George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
11. Topical clofibrate improves symptoms in patients with atopic dermatitis and reduces serum TARC levels: a randomized, double-blind, placebo-controlled pilot study.
Fukaya M; Kimata H
J Drugs Dermatol; 2014 Mar; 13(3):259-63. PubMed ID: 24595568
[TBL] [Abstract][Full Text] [Related]
12. Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial.
Navarro-López V; Ramírez-Boscá A; Ramón-Vidal D; Ruzafa-Costas B; Genovés-Martínez S; Chenoll-Cuadros E; Carrión-Gutiérrez M; Horga de la Parte J; Prieto-Merino D; Codoñer-Cortés FM
JAMA Dermatol; 2018 Jan; 154(1):37-43. PubMed ID: 29117309
[TBL] [Abstract][Full Text] [Related]
13. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
[TBL] [Abstract][Full Text] [Related]
14. Topical steroid therapy of atopic skin diseases.
Thiers BH
Allergy Proc; 1989; 10(6):413-6. PubMed ID: 2697633
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
16. Topical steroid withdrawal: an emerging clinical problem.
Brookes TS; Barlow R; Mohandas P; Bewley A
Clin Exp Dermatol; 2023 Aug; 48(9):1007-1011. PubMed ID: 37119282
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
[TBL] [Abstract][Full Text] [Related]
18. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis.
Arellano FM; Wentworth CE; Arana A; Fernández C; Paul CF
J Invest Dermatol; 2007 Apr; 127(4):808-16. PubMed ID: 17096020
[TBL] [Abstract][Full Text] [Related]
19. Managing pediatric atopic dermatitis.
Raimer SS
Clin Pediatr (Phila); 2000 Jan; 39(1):1-14. PubMed ID: 10660813
[TBL] [Abstract][Full Text] [Related]
20. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD).
Shaw M; Morrell DS; Goldsmith LA
Pediatr Dermatol; 2008; 25(1):19-24. PubMed ID: 18304147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
